Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting AMP‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib
Alicia Bort, Belén G. Sánchez, Pedro A. Mateos‐Gómez, et al.
Molecular Oncology (2019) Vol. 13, Iss. 5, pp. 1311-1331
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
Shunjie Xia, Yu Pan, Yuelong Liang, et al.
EBioMedicine (2020) Vol. 51, pp. 102610-102610
Open Access | Times Cited: 223
Mechanisms of drug resistance in HCC
Alexandra D. Ladd, Sergio Duarte, İlyas Şahin, et al.
Hepatology (2023)
Closed Access | Times Cited: 144
Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
Caiyan Liu, Shenshen Yang, Kailong Wang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 120, pp. 109543-109543
Open Access | Times Cited: 143
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
Loraine Kay D. Cabral, Claudio Tiribelli, Caecilia Sukowati
Cancers (2020) Vol. 12, Iss. 6, pp. 1576-1576
Open Access | Times Cited: 132
Role of CD36 in cancer progression, stemness, and targeting
Sandra Guerrero-Rodríguez, Cecilia Mata-Cruz, Sonia Mayra Pérez‐Tapia, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 53
Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity
Xueyao Wang, Rui Hu, Zhenwei Song, et al.
Cancer Letters (2022) Vol. 547, pp. 215880-215880
Closed Access | Times Cited: 47
NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway
Xiaomin Ma, Yumin Qiu, Yanlin Sun, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 3
Open Access | Times Cited: 65
Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin
Spiros Vlahopoulos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8621-8621
Open Access | Times Cited: 7
AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?
Fiona M. Russell, D. Grahame Hardie
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 186-186
Open Access | Times Cited: 49
<p>IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells</p>
Yumin Li, Gang Chen, Zhijian Han, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 9721-9730
Open Access | Times Cited: 40
Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells
Hongyang Huang, Yu‐Man Tsui, Irene Oi‐Lin Ng
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 5, pp. 1105-1116
Open Access | Times Cited: 13
Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells
Alicia Bort, Belén G. Sánchez, Irene de Miguel, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 4, pp. 2635-2647
Closed Access | Times Cited: 37
Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
Zhi Zeng, Qiliang Lu, Yang Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway
Chunyang Chen, He Wang, Xinyu Geng, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 29
The Natural Chemotherapeutic Capsaicin Activates AMPK through LKB1 Kinase and TRPV1 Receptors in Prostate Cancer Cells
Belén G. Sánchez, Alicia Bort, José María Mora-Rodríguez, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 329-329
Open Access | Times Cited: 19
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives
Prashant S. Kharkar
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15279-15307
Closed Access | Times Cited: 32
The potential anti-tumor effect of anesthetics on cancer by regulating autophagy
Tiantian Wang, Zhixia Zhou, Kai Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties
Yuting Wang, Fei Jiang, Kai Jiao, et al.
Experimental Cell Research (2019) Vol. 386, Iss. 2, pp. 111739-111739
Closed Access | Times Cited: 27
<p>Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect</p>
Huining Tian, Xiaoyu Zhu, You Lv, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 5957-5974
Open Access | Times Cited: 27
New tricks of old drugs: Repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies
Mei Zhang, Xianfeng Chen, Norbert Radacsi
Journal of Controlled Release (2020) Vol. 329, pp. 96-120
Open Access | Times Cited: 27
Sorafenib sensitization in tumor therapy by iron overload and AMPK activation
Jun Zhu, Shoujie Zhao, Yejing Zhu, et al.
Nano Research (2024) Vol. 17, Iss. 7, pp. 6386-6399
Closed Access | Times Cited: 2
Deciphering the Role of Mitochondrial DNA Targeted Therapy in Hepatic Cell Carcinoma
Madhunika Agrawal, Satyam Kumar Agrawal
Gene Expression (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Drug-Drug Interaction between Metformin and Sorafenib Alters Antitumor Effect in Hepatocellular Carcinoma Cells
Rania Harati, Marc Vandamme, Benoı̂t Blanchet, et al.
Molecular Pharmacology (2021) Vol. 100, Iss. 1, pp. 32-45
Open Access | Times Cited: 14
Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway
Qi Feng, Wenxing Qin, Yao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 14
Mechanisms of resistance to tyrosine kinase inhibitors in liver cancer stem cells and potential therapeutic approaches
Ki-Fong Man, Stephanie Ma
Essays in Biochemistry (2022) Vol. 66, Iss. 4, pp. 371-386
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top